TY - JOUR
T1 - Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus
AU - Guo, Yiwang
AU - Byer-Alcorace, Alexander
AU - Thomas, Cody
AU - Piekos, Stephanie
AU - Luo, Laibin
AU - Hawley, Michael
AU - Sun, Changquan Calvin
N1 - Publisher Copyright:
© 2024 American Pharmacists Association
PY - 2024/8
Y1 - 2024/8
N2 - In this work, the ability of the artificial stomach and duodenum (ASD) model to predict bioavailability in rats was investigated using a poorly soluble model compound, BI-639667. A solution and four suspensions of different solid forms of BI-639667 were tested both in an ASD and rats. Rank order of the bioavailability estimated from an ASD apparatus is consistent with that of in vivo result in rats, i.e., solution > salicylic acid cocrystal > malate salt > maleate salt > monohydrate, which correlates with the ability of the different solid forms to maintain supersaturation with respect to the stable form in aqueous solution. The results support the use of an ASD for characterizing dissolution performance of solid forms to aid their selection for tablet formulation development.
AB - In this work, the ability of the artificial stomach and duodenum (ASD) model to predict bioavailability in rats was investigated using a poorly soluble model compound, BI-639667. A solution and four suspensions of different solid forms of BI-639667 were tested both in an ASD and rats. Rank order of the bioavailability estimated from an ASD apparatus is consistent with that of in vivo result in rats, i.e., solution > salicylic acid cocrystal > malate salt > maleate salt > monohydrate, which correlates with the ability of the different solid forms to maintain supersaturation with respect to the stable form in aqueous solution. The results support the use of an ASD for characterizing dissolution performance of solid forms to aid their selection for tablet formulation development.
KW - Artificial stomach and duodenum
KW - BI-639667
KW - Biorelevant dissolution
KW - Cocrystal
KW - Salt
UR - http://www.scopus.com/inward/record.url?scp=85195097458&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85195097458&partnerID=8YFLogxK
U2 - 10.1016/j.xphs.2024.05.016
DO - 10.1016/j.xphs.2024.05.016
M3 - Article
C2 - 38768754
AN - SCOPUS:85195097458
SN - 0022-3549
VL - 113
SP - 2506
EP - 2512
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
IS - 8
ER -